Epizyme CEO Robert Bazemore's 2020 pay jumps 103% to $8.5M
Epizyme reports 2020 executive compensation
By ExecPay News
Published: April 29, 2021
Epizyme reported fiscal year 2020 executive compensation information on April 29, 2021.
In 2020, five Epizyme executives received on average a compensation package of $3.1M, a 38% increase compared to previous year.
Average pay of disclosed executives at Epizyme
Robert B. Bazemore Jr, Chief Executive Officer, received $8.5M in total, which increased by 103% compared to 2019. 49% of Bazemore's compensation, or $4.1M, was in option awards. Bazemore also received $371K in non-equity incentive plan, $650K in salary, $3.2M in stock awards, as well as $96K in other compensation.
For fiscal year 2020, the median employee pay was $333,249 at Epizyme. Therefore, the ratio of Robert B. Bazemore Jr's pay to the median employee pay was 25 to one.
Jeffery L. Kutok, Chief Scientific Officer, received a compensation package of $2.1M. 55% of the compensation package, or $1.1M, was in option awards.
Shefali Agarwal, Executive Vice President, Chief Medical and Development Officer, earned $1.8M in 2020, a 38% decrease compared to previous year.
Paolo Tombesi, Chief Financial Officer, received $1.7M in 2020, which decreases by 23% compared to 2019.
Matthew Ros, Executive Vice President, Chief Strategy and Business Officer, earned $1.6M in 2020, a 21% decrease compared to previous year.
Related executives
Robert Bazemore
Epizyme
Chief Executive Officer
Paolo Tombesi
Epizyme
Chief Financial Officer
Matthew Ros
Epizyme
Executive Vice President, Chief Strategy and Business Officer
Shefali Agarwal
Epizyme
Executive Vice President, Chief Medical and Development Officer
Jeffery Kutok
Epizyme
Chief Scientific Officer
You may also like
Source: SEC filing on April 29, 2021.